Met is involved in TIGAR-regulated metastasis of non-small-cell lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• TIGAR (TP53-inducible glycolysis regulator) is a p53 target gene.
• It protects cells from reactive oxygen species (ROS)-induced apoptosis by promoting the pentose phosphate pathway.
• The function of TIGAR in tumor cell invasion and metastasis is not well understood.

Purpose of the Study:

• To investigate the role of TIGAR in non-small cell lung cancer (NSCLC) cell invasion and metastasis.
• To explore the correlation between TIGAR expression and clinical outcomes in NSCLC patients.
• To elucidate the underlying molecular mechanisms involving the Met signaling pathway.

Main Methods:

• In vitro and in vivo assays were used to assess the effects of TIGAR downregulation on NSCLC cell invasion and metastasis.
• Immunohistochemical analysis was performed on 72 NSCLC patient samples.
• Correlation analysis and survival analysis were conducted to evaluate the clinical significance of TIGAR and Met expression.

Main Results:

• Downregulation of TIGAR significantly reduced NSCLC cell invasion and metastasis both in vitro and in vivo.
• TIGAR and Met protein expression levels were positively correlated with advanced stages of lung cancer.
• High co-expression of TIGAR and Met was associated with significantly worse patient survival.
• The Met signaling pathway was found to be involved in TIGAR-mediated invasion and metastasis.

Conclusions:

• The TIGAR/Met pathway represents a novel therapeutic target for NSCLC.
• Evaluating TIGAR expression is crucial before administering Met inhibitors for NSCLC treatment.